Inspire Medical Systems (INSP) Cash from Investing Activities (2017 - 2026)

Inspire Medical Systems has reported Cash from Investing Activities for 10 years, with the latest figure at -$11.2 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 624.34% year-over-year to -$11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (up 112.35% YoY) and the FY2025 annual result came in at $21.4 million, up 118.96% from the prior year.
• Cash from Investing Activities improved to -$11.2 million in Q1 2026 per INSP's latest filing, from -$11.9 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $46.6 million in Q2 2025 and troughed at -$151.7 million in Q4 2023.
• A 5-year average of -$24.5 million and a median of -$3.8 million in 2022 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities plunged 5043.15% in 2023, then surged 728.51% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$2.9 million in 2022, then slumped by 5043.15% to -$151.7 million in 2023, then jumped by 102.48% to $3.8 million in 2024, then tumbled by 416.88% to -$11.9 million in 2025, then advanced by 5.61% to -$11.2 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$11.2 million, -$11.9 million, and -$11.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.